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Rural Health Network
• Our purpose is to elevate rural healthcare by tunneling information,
developing services and assisting rural pharmacists in the
advancement and improvement of patient care.
•
•
•
•
•
•
•

Rural Rocks
Health Fairs
Immunization Training
Pharmacy and Hospital Visits
Mission Trip
Ipad Medication Use Counseling videos
Rural Health Network Website and Resources
• http://www.swosu.edu/academics/pharmacy/rhn/index.aspx

• Remote Medication Order Processing
• Transitional Care Medication Reconciliation Discharge Counseling
• Medication Therapy Management

Rural Healthcare
• Rural residents have access to fewer healthcare services,
lower economic and insurance status, fewer physicians per
capita, and higher chronic disease rates than their urban
peers.
• In the past year alone, more rural hospitals closed than in the
prior 15 years combined.
Maintaining long-term viability of critical access hospitals
(CAH) will be essential for rural healthcare delivery.

Medicare Beneficiary Quality
Improvement Project
Critical Access Hospitals & Small Hospital Improvement Program Grantees in Oklahoma
2013

Adverse Drug Events
• Account for 34.2 % of all hospital acquired conditions.
• Each hospitalized patient on average is subjected to more
than one medication error per day.
• Processing a prescription drug order through a
Computerized Provider Order Entry (CPOE) system cuts
the likelihood of error on that order by 48%.

MBQIP Meaningful Use
Phase 3 Measure
• Pharmacist CPOE/Verification of Medication Orders within 24
hours
• Numerator: Number of electronically entered medication orders
for an inpatient admitted to a CAH (acute or swing-bed), verified
by a pharmacist or directly entered by a pharmacist within 24
hours
• Denominator: Total number of electronically entered medication
orders for an inpatient admitted to CAH (acute or swing-bed)
during the reporting period

• Inclusion/Exclusion Criteria:
• Included: Inpatients admitted to acute care bed, swing bed;
observation patients
• Excluded: Outpatients; ED patients

Pharmacist Verification Report
> Generated by your computerized pharmacy system or
electronic health record (EHR).
• Minimum data elements in report should include:
• Date for each order
• Time ordered
• Time verified (or "no verification required" because it was
entered by the pharmacist)
• Total number of orders verified or entered by pharmacist within
24 hours
Total number of orders entered

Remote Medication Order
Processing
(RMOP)
• Serves small rural hospitals in Oklahoma
• Reviews medication orders remotely for contracted hospitals
in the absence of a pharmacist
• Hospital Drug Room--152 in Oklahoma
• Consultant Pharmacist--52 visits per year

• All orders reviewed within 24 hours, 7 days a week
• Appropriateness of drug, dose, route, frequency, allergies and
other drug or disease interactions
• Clinical knowledge for review of inpatient chart

Adverse Drug Events
• Defined as harm experienced by a patient as a result of exposure to
a medication
• Account for nearly 700,000 emergency department visits and
100,000 hospitalizations each year
• Affect nearly 5% of hospitalized patients, making them one of the
most common types of inpatient errors

By detecting and preventing adverse drug events, a hospital can
reduce expenses while providing better quality care to its patients.

STAGE
Prescribing

SAFETY STRATEGY
•

Avoid unnecessary medications by adhering to conservative prescribing principles

•

Computerized provider order entry, especially when paired with clinical decision support
systems

•

Medication reconciliation at times of transitions in care

Transcribing

•

Computerized provider order entry to eliminate handwriting errors

Dispensing

•

Clinical pharmacists to oversee medication dispensing process

•

Use of "tall man" lettering and other strategies to minimize confusion between look-alike,
sound-alike medications

Administration

•

Adherence to the "Five Rights" of medication safety (administering the Right Medication, in the
Right Dose, at the Right Time, by the Right Route, to the Right Patient)

•

Barcode medication administration to ensure medications are given to the correct patient

•

Minimize interruptions to allow nurses to administer medications safely

•

Smart infusion pumps for intravenous infusions

•

Patient education and revised medication labels to improve patient comprehension of
administration instructions

*Table provided by Agency for Healthcare Research and Quality Patient Safety Network ©2013
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Compliance with Federal and State Laws and Regulations
Minimum Technical Standards and Specifications
Confidentiality, Privacy and Security and General Issues
Pharmacist Training, Orientation, and Competencies
Workload Balancing and Staffing Levels
Drug Information Resources
Communication and Problem Resolution
Quality Assurance and Medication Error Reporting Systems
Medication Errors
Pharmacist Order Verification and Exceptions
Medication Orders
Questionable Medication Orders
Pharmacist Therapeutic Intervention
Creatinine Level Assessment
Renal Dosing Adjustments
Performance Improvement Plan
Record Keeping, Reports, Annual Review, Documentation
Pharmacist Consult Form
Potential Adverse Drug Reaction Form
Adverse Drug Reaction Reporting Form

Adverse Drug Reaction
Reporting Form
Date of Reaction:

_____________________

Suspected Drug:

___________________________________________________ Start Date:

Known A lle rg ie s :_______________________

C oncurrent Drugs:

______________________________________________________________

Describe Reaction: ______________________________________________________________
Gi
Nausea
Vom iting
Diarrhea
Constipation
GI Upset
G I Pain
W as the Physician Notified:
□ Yes
Circle all that apply:

SKIN
Rash
Itching
Flushing
Swelling
Phlebitis
Erythema
□ No

CV
Hypertension
Hypotension
Chest Pain
Arrhythmias
Bradycardia
Tachycardia

CNS
Headache
Confusion
Anxiety
Sedation
Depression
Malaise

T reatm ent o f reaction: (Circle or list drugs prescribed or actions taken.)
Discontinued drug
Epinephrine
Kayexalate
Decrease dose
Hydroxyzine
Naloxone
Obtain drug level
Insulin
Phytadione
Diphenhydramine
Digibind
Protamine
Dextrose
Glucagon
Meclizine

LABS
LFTs
Scr/BUN
Neutropenia
Anemia
Electrolyte

Benztropine
Physostigmine
Blood Products
Romazicon
Steroids

OTHER
Short of Breath
Wheezing
Fever
Chills
Seizures
Shock

Vancomycin PO
Other: ________
_____________
_____________
_____________

PR EVENTABILITY ASSESSM EN T
1.
2.
3.
4.
5.

W as the drug involved in the A D R inappropriate for the patient’s clinical condition?
Were the dose, route and frequency of administration appropriate for the patient’s age, weight, organ function and disease
state?
If the reaction w as due to a drug allergy, w as this allergy previously documented?
□ Admitting orders
□ Pharm acy computer
□ Nursing Kardex
Were appropriate therapeutic drug monitoring or other laboratory tests performed, which may have predicted this reaction?
(include toxic serum levels)
Reaction involved a drug-drug, drug-food or drug-lab interaction.
SE VER ITY ASSESSM EN T

1.
2.
3.
4.
5.
6.
7.
8.

An A D R occurred but required no change in treatment with the suspected drug.
The A D R required that treatment with the suspected drug be held, discontinued or otherwise changed. No antidote or other
treatment required. No increase in length of stay.
The A D R required that treatment with the suspected drug be held, discontinued or otherwise changed A N D / O R an antidote or
other treatment w as required.
Serious A D R , but drug’s benefits outweigh the adverse effects; drug is continued.
The A D R w as the reason for admission.
The A D R treatment required intensive medical care. Increase length of stay.
The A D R caused permanent harm to the patient.
The A D R directly or indirectly led to the death of the patient.
THESE TYPES O F AD R ARE REPO RTABLE TO THE FDA - M ED W ATCH

1. The suspected drug has been on the market for less than two years.
2. The reaction is not listed in the package insert.
3. The reaction is attributed to an investigational drug.
4. The reaction contributed to the death of the patient.
5. The reaction w as life-threatening or permanently disabling.
T his information will remain confidential. Upon completion of the form, return to the ____________________ Department.
Com pleted by:

Date:

Pharmacist Intervention Form
Initiated by:

•
•
•
•
•
•
•
•
•

•

•

, RPH
Other
, RN
Patient Name:
Room #:
Medical Record #:
Nature of Consult:
Date/Time:____
Order clarification required (omission of dose, route, etc.)__________
Dosing is too FREQUENT/INFREQUENT
Medication:_____________ Dosing Interval:______________
Duration of therapy too PROLONGED/PROTRACTED________________
Potential drug-drug INTERACTION/INCOMPATIBILITY
Drugs involved:_____________________________
Potential need to change medications secondary to allergy history
Allergy:___________ Medication:____________
Questionable indication for use
Indication:______________ Medication:______________
Alternative agent recommended in view of patient's condition.
(Include IV to PO as less costly therapeutic alternative)
Prescribed Agent:____________ Alternative:_____________
Medication:_____________
Non-Formulary drug
Medication Requested:_________Recommended Alternative:_______
Drug information requested (briefly describe)_____________________
Other/further explanation:_______________________
OUTCOME OF CONSULT
□ Order clarified/drug information provided
□ Change made according to Pharmacist's suggestion
□ Justification by physician acceptable to Pharmacist
□ Case resolved, forward to Pharmacy and Therapeutics Committee
Date/Time Resolved:________
Pharmacist:_____________ Date:________

, MD

2014

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

To tal H ours P h arm acist on D uty
To tal N u m b e r o f O rd e rs R e v ie w e d
To tal N u m b e r o f O rd e rs En tered
P o te n tia l D rug In te ra ctio n s C o m m u n ic a te d 1
To tal N u m b e r o f In te rv e n tio n s

Breakdown
M e d icatio n Erro rs2
T ra n scrip tio n Errors
M e d icatio n Error R a te 3
O rd e r c la rific a tio n s4
T h e ra p e u tic C han ge R e c o m m e n d a tio n s5
T h e ra p e u tic M o n ito rin g R e c o m m e n d a tio n s6
D o sin g Is su e s7
R e q u e st fo r O rd e rs8
R e q u e st fo r A d d itio n a l In fo rm a tio n 9

1This is a service to make the practioner aw are of potential drug interactions that can occur due to multiple medications that the patient is taking and to indicate how the adverse result may present.
2 Many of these errors are transcription errors involving a w rong medication, dosage form, dose, frequency, route of administration, or scheduling w hen the medication is entered into the computer system or onto
the MAR. The errors may or may not have been corrected prior to the first dose given and therefore may or may not have resulted in an actual medication error involving the patient.

3Number of medication errors as a per cent of total number or orders reviewed. (Not total number of doses.)
4

These result w hen there is inadequate information contained in the physician's order. More information is needed to complete entry into the computer system or review of the order previously entered.
Pharmacists also use this to communicate the need for home medications to be brought from home as w ell as any automatic substitutions that may have been used during order entry.

5These result w hen there is a therapeutic or economic reason to change an order. (ex. Duplicate therapy, change of route from V to oral, etc.)
6These result w hen a high dose or drug potentiation merits monitoring clinical lab values or vitals.
7Such as exceeding maximum recommended dose, inappropriate frequency or route of administration.
8Results w hen medication administration record indicates an order entered w ithout the faxed order available for review . (a performance improvement monitor)
9 Includes discussion such as patient allergies, lab values, age, weight, etc.

Transitional Care
• Care transitions are complex and vulnerable to medical error,
especially adverse drug events
• Occur when a patient moves from one health care provider or
setting to another
• Nearly 1 in 5 Medicare patients discharged from a hospital is
readmitted within 30 days
• Of the 1.5 million medication errors that harm patients each
year, approximately 60% occur during transitions of care.
The Joint Commission's National Patient Safety Goals require
health care organizations to "accurately and completely
reconcile medications across the continuum of care."

Transitional Care
• Nearly two-thirds of post-discharge adverse events are
medication related
• 29% of these adverse drug events (ADE's) are serious or life
threatening, resulting in emergency department visits and
unscheduled hospital admissions
• As many as 60% of post discharge ADE's could be prevented
with intervention by health care professionals at discharge or
shortly thereafter
• Preventable ADE's resulting in hospital admissions are
estimated to increase the cost of care to the health system by
$3.8 million per year, with nonadherence being the main
cause for ADE admissions

Role of the Pharmacist
• Redesigned discharge processes that incorporate:
• Pharmacist-specific interventions
• Medication reconciliation
• Patient counseling
• Follow-up telephone calls

• Results in identification and resolution of medication
discrepancies
• Reduces the incidence of preventable adverse drug events
after discharge
• Decreases the number of return visits to the emergency
department

Medication Therapy
Management (MTM)
• Handoff from Transitional Care to the pharmacy
• Continuity of information transfer
• Keeps pharmacy updated on current treatment
• Enhances patient understanding

• Focuses on Patient Centered Care
• Complete Medication Review
• Target Interventions
• Patient Adherence
• Monitors patient's clinical condition
• Control Cost

Medication Therapy
Management
•

Performing necessary assessments of the patient's health status;

•

Formulating a medication treatment plan;

•

Selecting, initiating, modifying, or administering medication therapy;

• Monitoring and evaluating the patient's response to therapy, including safety and effectiveness;
•

Performing a comprehensive medication review to identify, resolve, and prevent medication-related
problems, including adverse drug events;

•

Documenting the care delivered and communicating essential information to the patient's other
primary care providers;

•

Providing verbal education and training designed to enhance patient understanding and appropriate use
of his/her medications;

•

Providing information, support services and resources designed to enhance patient adherence with
his/her therapeutic regimens;

•

Coordinating and integrating medication therapy management services within the broader health caremanagement services being provided to the patient.
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